Skip to main content

Table 2 AKI patient characteristics by outcome.

From: Fluid balance and urine volume are independent predictors of mortality in acute kidney injury

 

All AKI (number = 132)

Survivors (number = 66)

Non-Survivors (number = 66)

P

Male gender

84 (63.6%)

43 (34.8%)

41 (62.1%)

0.86

Age (years)

66.3 ± 14.1

68.5 (38 to 57.5)

63.1 ± 15.6

64 (52.8 to 76)

69.5 ± 11.7

74 (61 to 78.3)

0.015

ICU Admission

SAPS II

50.0 ± 14.5

48 (38 to 57.5)

46.3 ± 13.5

42 (37 to 52.8)

53.7 ±14.6

51.5 (43.8 to 61.3)

0.001

SOFA

8.0 ± 4.1

7 (5 to 11)

6.8 ± 3.6

7 (4 to 9.3)

9.2 ± 4.3

8.5 (6 to 12)

0.002

Non-renal SOFA

6.6 ± 3.5

6 (4 to 9)

5.4 ± 2.9

5 (3 to 7)

7.8 ± 3.6

7 (5 to 11)

<0.001

APACHE II

22.3 ± 8.4

21 (16 to 28)

20.3 ± 7.7

19 (15 to 25.3)

24.4 ± 8.6

24 (16.8 to 31)

0.006

Vasoactive therapy

56 (42.4%)

21 (31.8%)

35 (53.0%)

0.022

Mechanical ventilation

96 (72.7%)

44 (66.7%)

52 (78.8%)

0.17

Serum creatinine (mg/dL)

2.3 ± 2.0

1.45 (0.9 to 3.2)

2.3 ± 2.0

1.4 (0.9 to 3.1)

2.4 ± 2.1

1.5 (0.8 to 3.3)

0.99

Comorbid diseases

Diabetes

41 (31.1%)

20 (30.3%)

21 (31.8%)

1

Cardiovascular

66 (50.0%)

31 (47.0%)

35 (53.0%)

0.60

Hypertension

67 (50.8%)

29 (43.9%)

38 (57.6%)

0.16

Chronic kidney disease

19 (14.4%)

10 (15.2%)

9 (13.6%)

1

Metastatic carcinoma

4 (3.0%)

3 (4.5%)

1 (1.5%)

0.62

Hematologic malignancy

6 (4.5%)

2 (3.0%)

4 (6.1%)

0.68

Category of ICU admission diagnosis

Respiratory

44 (33.3%)

20 (30.3%)

24 (36.4%)

0.58

Neurologic

15 (11.4%)

9 (13.6%)

6 (9.1%)

0.59

Trauma

8 (6.1%)

5 (7.6%)

3 (4.5%)

0.72

Cardiovascular

25 (18.9%)

12 (18.2%)

13 (19.7%)

1

Sepsis

15 (11.4%)

6 (9.1%)

9 (13.6%)

0.59

ICU course

Sepsis

61 (46.2%)

23 (34.8%)

38 (57.6%)

0.014

Early AKI (%)

83 (62.9%)

39 (59.1%)

44 (66.7%)

0.47

Mean fluid balance/24hours (L)

0.74 ± 1.16

0.48 (0.02 to 1.26)

0.17 ± 0.72

0.02 (-0.17 to 0.48)

1.31 ± 1.24

1.09 (0.49 to 1.85)

<0.001

Oliguria

91 (68.9%)

36 (54.5%)

55 (83.3%)

0.001

Duration of oliguria (days)

2.8 ± 5.9

1 (0 to 3)

1.6 ± 4.0

1 (0 to 1)

4.0 ± 7.2

2 (1 to 4)

<0.001

% of ICU days with oliguria

24.6 ± 30.8%

11.9% (0 to 37.1%)

13.6 ± 21.9%

2.8% (0 to 20.7%)

35.5 ± 34.5

25% (6.7 to 62.0%)

<0.001

Mean urine volume/24hour(L)

1.81 ± 1.08

1.88 (0.87 to 2.73)

2.35 ± 0.98

2.49 (1.61 to 3.12)

1.28 ± 0.90

1.22 (0.55 to 1.96)

<0.001

Use of diuretics (%)

102 (77.3%)

55 (83.3%)

47 (71.2%)

0.15

Duration of diuretic use (days)

8.3 ± 11.3

4 (1 to 10.8)

10.3 ± 13.5

4.5 (1 to 13)

6.4 ± 8.3

3 (0 to 10)

0.11

% of ICU days receiving diuretics

51.0 ± 37.6

51.9% (8.7 to 87.5%)

56.2 ± 36.7%

55.6% (20 to 93.0%)

45.9 ± 38.1%

46.9% (0 to 82.6%)

0.11

Outcomes

RRT

67 (50.8%)

31 (47.0%)

36 (54.5%)

0.49

Duration of RRT (days)(% of ICU days)

3.2 ± 6.9

1 (1 to 3)

2.2 ± 4.3

0 (0 to 3)

4.1 ± 8.7

1.5 (0 to 5)

0.14

% of ICU days on RRT

23.3 ± 31.3%

3.9% (0 to 45.2%)

15.4 ± 24.1%

0% (0 to 21.6%)

31.1 ± 35.6%

6.7% (0 to 66.7%)

0.03

RRT free days

12.1 ± 13.9

8 (3 to 16.8)

15.1 ±17.1

9 (3 to 23.3)

9.1 ± 8.8

6.5 (2.8 to 13)

0.06

Length of ICU stay (days)

15.3 ± 16.3

10 (5 to 20)

17.4 ± 18.7

11.5 (5 to 24)

13.2 ±13.2

9 (4 to 19.3)

0.45

  1. AKI, acute kidney injury; SAPS II, Simplified Acute Physiology Score II; SOFA, Sequential Organ Failure Assessment; APACHE II, Acute Physiology and Chronic Health Evaluation II; RRT, renal replacement therapy.